Arun Azad

Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19.

Xuan Rui Sean Ong, Benjamin Condon, Dominic Bagguley, Nathan Lawrentschuk, Arun Azad, Declan Murphy

Journal article  |  2020  |  Future Oncology

Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer.

Heidi Fettke, Edmond M Kwan, Maria M Docanto, Patricia Bukczynska, Nicole Ng, Lisa-Jane K Graham, Kate Mahon, Christine Hauser, Winston Tan, Xiao Hong Wang, Zhixin Zhao, Tiantian Zheng, Kemin Zhou, Pan Du, Jianjun Yu, Yong Huang, Shidong Jia, Manish Kohli, Lisa G Horvath, Arun A Azad

Journal article  |  2020  |  European Urology

BACKGROUND: The androgen receptor (AR) remains a critical driver in metastatic castration-resistant prostate cancer (mCRPC). Profi..

Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer

Manish Kohli, Winston Tan, Tiantian Zheng, Amy Wang, Carlos Montesinos, Calven Wong, Pan Du, Shidong Jia, Siddhartha Yadav, Lisa G Horvath, Kate L Mahon, Edmond M Kwan, Heidi Fettke, Jianjun Yu, Arun A Azad

Journal article  |  2020  |  EBioMedicine

BACKGROUND: Metastatic prostate cancer is a clonally heterogeneous disease state characterized by progressive somatic perturbation..

Lutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies

Amir Iravani, John Violet, Arun Azad, Michael S Hofman

Journal article  |  2020  |  Prostate Cancer and Prostatic Diseases

Theranostic principles utilize a molecular biomarker specific for a tumor target, initially for imaging to assess target expressio..

Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis

Niranjan J Sathianathen, Samantha Koschel, Isaac A Thangasamy, Jiasian Teh, Omar Alghazo, Georgiana Butcher, Harriet Howard, Jada Kapoor, Nathan Lawrentschuk, Shankar Siva, Arun Azad, Ben Tran, Damien Bolton, Declan G Murphy

Journal article  |  2020  |  European Urology

CONTEXT: There have been substantial changes in the management of men with metastatic hormone-sensitive prostate cancer (mHSPC) ov..

Plasma cell-free DNA (cfDNA) profiling of copy number variation (CNV) to identify poor prognostic biomarkers in metastatic castration-resistant prostate cancer (mCRPC)

Edmond Michael Kwan, Heidi Fettke, Patricia Bukczynska, Nicole Ng, Christine Hauser, Lisa-Jane K Graham, Kate Lynette Mahon, Chao Dai, Feng Xie, Xiaohong Wang, Zhixin Zhao, Kemin Zhou, Peter Du, Jianjun Yu, Shidong Jia, Winston Tan, Lisa Horvath, Manish Kohli, Arun Azad

Conference Proceedings  |  2020  |  JOURNAL OF CLINICAL ONCOLOGY

Results of a phase I/II prospective dose-escalation trial evaluating safety and efficacy of combination 177LuPSMA-617 and NOX66 in men with mCRPC post androgen signalling inhibition and two lines of taxane chemotherapy (LuPIN trial)

Louise Emmett, Sarennya Pathmanandavel, Andrew Nguyen, Megan Crumbaker, Andrew On Wah Yam, Wai Ling Chan, Karen Fullard, Bao Ho, Arun Azad, Anthony M Joshua

Conference Proceedings  |  2020  |  JOURNAL OF CLINICAL ONCOLOGY

Treatment outcomes for metastatic castrate-resistant prostate cancer (mCRPC) patients (pts) following docetaxel (D) for hormone sensitive disease

Andrew Lachlan Schmidt, Angelyn Anton, Shirley S Wong, Arun Azad, Edmond Michael Kwan, Lavinia Anne Spain, Javier Torres, Arunbalaji Muthusamy, Phillip Parente, Francis Parnis, Jeffrey C Goh, Anthony M Joshua, David William Pook, Peter Gibbs, Ben Tran, Andrew James Weickhardt

Conference Proceedings  |  2020  |  JOURNAL OF CLINICAL ONCOLOGY

TALAPRO-2: A placebo-controlled phase III study of talazoparib (TALA) plus enzalutamide (ENZA) for patients with first-line metastatic castration-resistant prostate cancer (mCRPC)

Neeraj Agarwal, Neal D Shore, Curtis Dunshee, Lawrence Ivan Karsh, Arun Azad, Andre P Fay, Joan Carles, Beth Sullivan, Nicola Di Santo, Mohamed Elmeliegy, Xun Lin, Ruben GW Quek, Akos Czibere, Karim Fizazi

Conference Proceedings  |  2020  |  JOURNAL OF CLINICAL ONCOLOGY

Navigating systemic therapy for metastatic castration-naive prostate cancer

EM Kwan, IA Thangasamy, J Teh, O Alghazo, NJ Sathianathen, N Lawrentschuk, AA Azad

Journal article  |  2020  |  World Journal of Urology

Re: PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients with Metastatic Castration-resistant Prostate Cancer

Daniel McLennan, Niranjan Sathianathen, Omar Alghazo, Arun Azad, Declan G Murphy

Journal article  |  2020  |  European Urology

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

Daniel J Khalaf, Matti Annala, Sinja Taavitsainen, Daygen L Finch, Conrad Oja, Joanna Vergidis, Muhammad Zulfiqar, Katherine Sunderland, Arun A Azad, Christian K Kollmannsberger, Bernhard J Eigl, Krista Noonan, Deepa Wadhwa, Andrew Attwell, Bruce Keith, Susan L Ellard, Lyly Le, Martin E Gleave, Alexander W Wyatt, Kim N Chi

Journal article  |  2019  |  The Lancet Oncology

Novel agents for metastatic hormone-sensitive prostate cancer - a practice guide for urologists

Isaac A Thangasamy, Edmond M Kwan, Jiasian Teh, Niranjan Sathianathen, Omar Alghazo, Shankar Siva, Arun Azad, Declan G Murphy

Journal article  |  2019  |  BJU International

The last five years has witnessed a remarkable evolution in the management of metastatic hormone-sensitive prostate cancer (mHSPC)..

Open-label, multicenter phase 1/2 dose escalation and expansion study of THOR-707 as a single agent and in combination with a PD-1 inhibitor in adult subjects with advanced or metastatic solid tumors

David Luo, Raghad Abdul-Karim, Arun Azad, Joanna Bendell, Hui Gan, Filip Janku, Shiraj Sen, Tira Tan, Judy Wang, Lisa Schechet, Lauren Baker, Joseph Leveque, Tarek Meniawy

Conference Proceedings  |  2019  |  JOURNAL FOR IMMUNOTHERAPY OF CANCER

Treatment selection for first-line metastatic renal cell carcinoma in Australia: Impact of new therapy options

Andrew Schmidt, Arun Azad, Jeffrey Goh, Carole Harris, Anthony M Joshua, Andrew Weickhardt, Laurence Krieger

Journal article  |  2019  |  Asia-Pacific Journal of Clinical Oncology

Ga-68-prostate-specific membrane antigen (PSMA) PET/CT as a clinical decision-making tool in biochemically recurrent prostate cancer after definitive treatment: An Australian prospective study

Amy Davies, Edmond M Kwan, John Kourambas, Nicholas Redgrave, Scott Donnellan, Sree Appu, Scott Williams, Andrew Coleman, Marcus Foo, Shakher Ramdave, Arun Azad

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Metastatic hormone-sensitive prostate cancer: A new era

Arun Azad

Conference Proceedings  |  2019  |  Asia-Pacific Journal of Clinical Oncology

TheraP: a randomized phase 2 trial of Lu-177-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

Michael S Hofman, Louise Emmett, John Violet, Alison Y Zhang, Nicola J Lawrence, Martin Stockler, Roslyn J Francis, Amir Iravani, Scott Williams, Arun Azad, Andrew Martin, Margaret McJannett, Ian D Davis

Journal article  |  2019  |  BJU International

OBJECTIVE: To assess the activity and safety of cabazitaxel chemotherapy vs that of treatment with 177 Lu-PSMA-617, a novel radiol..

Safety of Pembrolizumab Combined with Stereotactic Ablative Body Radiotherapy (SABR) for Pulmonary Oligometastases

S Siva, M Bressel, S Loi, S Sandhu, B Tran, J Mooi, J Lewin, A Azad, D Colyer, M Shaw, S Chander, K Cuff, S Wood, N Lawrentschuk, D Murphy, D Pryor

Conference Proceedings  |  2019  |  Journal of Thoracic Oncology

Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?

Ramin Alipour, Arun Azad, Michael S Hofman

Journal article  |  2019  |  Therapeutic Advances in Medical Oncology

Going nuclear: it is time to embed the nuclear medicine physician in the prostate cancer multidisciplinary team

Declan G Murphy, Michael S Hofman, Arun Azad, John Violet, Rodney J Hicks, Nathan Lawrentschuk

Journal article  |  2019  |  BJU International

Real-World Use of First-Generation Anti-androgens (FGAs): Their Influence on Patient Outcomes and Subsequent Therapies in Metastatic Castration-Resistant Prostate Cancer (mCPRC)

Richard Kelly, Angelyn Anton, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun Azad, Edmond Kwan, Lavinia Spain, Arun Muthusamy, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Anthony Joshua, David Pook, Peter Gibbs, Ben Tran

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Prognostic and predictive utility of copy number variations (CNVs) in circulating tumor DNA (ctDNA) from metastatic castration-resistant prostate cancer (mCRPC) patients

Heidi Fettke, Edmond M Kwan, Jianjun Yu, Amy Wang, Carlos Montesinos, Calvin Wong, Xue Gong, Tiantian Zheng, Peter Pan Du, Shidong Jia, Andrew Mant, Phillip Parente, Carmel Pezaro, Arun A Azad

Conference Proceedings  |  2019  |  Clinical Research (Excluding Clinical Trials)

Australian Treatment Practices for Patients with Metastatic Renal Cell Carcinoma (MRCC)

Elizabeth Liow, Olivia Baenziger, Claudia Corrente, Nicholas Law, Arun Azad, Julia Shapiro, Jeremy Shapiro, Andrew Weickhardt, Andrew Schmidt, Francis Parnis, Shirley Wong, Phillip Parente, Angelyn Anton, Carmel Pezaro, Ben Tran

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Whole Blood Androgen Receptor-Based Gene Signature as a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer

Edmond M Kwan, Heidi Fettke, Maria M Docanto, Sarah Q To, Patricia Bukczynska, Andrew Mant, David Pook, Nicole Ng, Lisa-Jane K Graham, Stefano Mangiola, Eva Segelov, Kate Mahon, Ian D Davis, Phillip Parente, Carmel Pezaro, Tilman Todenhoefer, Lisa G Horvath, Arun A Azad

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Prognostic and Predictive Utility of Copy Number Variations (CNVS) in Circulating Tumour DNA (CTDNA) from Metastatic Castration-Resistant Prostate Cancer (MCRPC) Patients

Heidi Fettke, Edmond M Kwan, Jianjun Yu, Amy Wang, Carlos Montesinos, Calvin Wong, Xue Gong, Tiantian Zheng, Peter Pan Du, Shidong Jia, Andrew Mant, Phillip Parente, Carmel Pezaro, Arun A Azad

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Prostate-specific Membrane Antigen Across the Spectrum of Prostate Cancer: Detection, Surgery, and Theranostics

Declan G Murphy, Arun A Azad, Shahneen Sandhu, John Violet, Michael S Hofman

Journal article  |  2019  |  European Urology

Updated results from a randomized phase II study of cabazitaxel (CAB) versus abiraterone (ABI) or enzalutamide (ENZ) in poor prognosis metastatic CRPC.

Kim N Chi, Sinja Taavitsainen, Nayyer Iqbal, Cristiano Ferrario, Michael Ong, Deepa Wadhwa, Sebastien J Hotte, Gregory Lo, Ben Tran, Arun Azad, Lori Wood, Joel Roger Gingerich, Scott A North, Carmel Jo Pezaro, Joseph D Ruether, Srikala S Sridhar, Jack Bacon, Gillian Vandekerkhove, Matti Annala, Alexander William Wyatt

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Prognostic Utility of a Whole-blood Androgen Receptor-based Gene Signature in Metastatic Castration-resistant Prostate Cancer.

Edmond M Kwan, Heidi Fettke, Maria M Docanto, Sarah Q To, Patricia Bukczynska, Andrew Mant, David Pook, Nicole Ng, Lisa-Jane K Graham, Stefano Mangiola, Eva Segelov, Kate Mahon, Ian D Davis, Phillip Parente, Carmel Pezaro, Tilman Todenhöfer, Lisa G Horvath, Arun A Azad

Journal article  |  2019  |  European Urology Focus

BACKGROUND: The treatment paradigm for metastatic castration-resistant prostate cancer (mCRPC) has evolved significantly in recent..

Interim results of a Phase I/II prospective dose escalation trial evaluating safety and efficacy of combination Lu-177 PSMA 617 and NOX66 in men with mCRPC post androgen signalling inhibition and 2 lines of taxane chemotherapy (LuPIN trial)

Louise Emmett, Megan Crumbaker, Andrew Nguyen, Bao Ho, Charlotte Yin, Noah Isheish, Arun Azad, John Violet, Shikha Sharma, Anthony Joshua

Conference Proceedings  |  2019  |  JOURNAL OF NUCLEAR MEDICINE

Where to Next for Theranostics in Prostate Cancer?

Declan G Murphy, Niranjan Sathianathen, Michael S Hofman, Arun Azad, Nathan Lawrentschuk

Journal article  |  2019  |  European Urology Oncology

TheraP: A randomized phase II trial of [Lu-177]-PSMA-617 theranostic versus cabazitaxel in progressive metastatic castration-resistant prostate cancer

Michael Hofman, Louise Emmett, John A Violet, Nicola Jane Lawrence, Scott Williams, Martin R Stockler, Roslyn J Francis, Amir Iravani, Alison Yan Zhang, Andrew James Martin, Arun Azad, Sonia Yip, Ailsa Langford, Margaret Mary McJannett, Ian D Davis

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Whole blood FOLH1 mRNA expression and treatment response in metastatic castration-resistant prostate cancer (mCRPC).

Edmond Michael Kwan, Sarah Q To, Heidi C Fettke, Maria M Docanto, Patricia Bukczynska, Andrew Michael Mant, David William Pook, Nicole Ng, Lisa-Jane K Graham, Eva Segelov, Kate Mahon, Ian D Davis, Phillip Parente, Carmel Jo Pezaro, Lisa Horvath, Arun Azad

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Phase III study of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): The ARCHES trial.

Andrew J Armstrong, Russell Zelig Szmulewitz, Daniel Peter Petrylak, Arnauld Villers, Arun Azad, Antonio Alcaraz, Boris Y Alekseev, Taro Iguchi, Neal D Shore, Brad Rosbrook, Jennifer Sugg, Benoit Baron, Lucy F Chen, Arnulf Stenzl

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Cell-free DNA in cancer: current insights

Heidi Fettke, Edmond M Kwan, Arun A Azad

Journal article  |  2019  |  Cellular Oncology

BACKGROUND: The field of liquid biopsies in oncology is rapidly expanding, with the application of cell-free circulating tumour DN..

Radiotherapy and immunotherapy: a synergistic effect in cancer care

Guy-Anne Turgeon, Andrew Weickhardt, Arun A Azad, Benjamin Solomon, Shankar Siva

Journal article  |  2019  |  Medical Journal of Australia

Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy

Mitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, Luke A Selth, Stephen Q Wong, Laura H Porter, Natalie Lister, David Pook, Carmel J Pezaro, David L Goode, Richard J Rebello, Ashlee K Clark, Melissa Papargiris, Jenna Van Gramberg, Adrienne R Hanson, Patricia Banks, Hong Wang, Birunthi Niranjan, Shivakumar Keerthikumar, Shelley Hedwards, et al.

Journal article  |  2018  |  European Urology

A randomized phase II study of cabazitaxel (CAB) vs (ABI) abiraterone or (ENZ) enzalutamide in poor prognosis metastatic castration-resistant prostate cancer (mCRPC)

KN Chi, S Taavitsainen, N Iqbal, C Ferrario, M Ong, D Wadhwa, SJ Hotte, G Lo, B Tran, A Azad, L Wood, JR Gingerich, S North, CV Pezaro, D Ruether, SS Sridhar, M Annala, J Bacon, AW Wyatt

Conference Proceedings  |  2018  |  ANNALS OF ONCOLOGY

Whole blood assay for rapid detection of AR-v7 in metastatic castration-resistant prostate cancer: No correlation with response to androgen-axis targeting agents.

Sarah To, Edmond Kwan, Heidi Fettke, Maria Docanto, Nicole Ng, Andrew Mant, Phillip Parente, Carmel Pezaro, Lisa Horvath, Lisa Graham, Tilman Todenhofer, Arun Azad

Conference Proceedings  |  2018  |  Oral Presentations - Proffered Abstracts

AR-V7 and AR-V9 expression is not predictive of response to AR-axis targeting agents in metastatic castration-resistant prostate cancer

Sarah Q To, Edmond Kwan, Heidi Fettke, Andrew Mant, Maria Docanto, Luciano Martelotto, Patricia Bukczynska, Nicole Ng, Lisa-Jane Graham, Phillip Parente, Carmel Pezaro, Kate Mahon, Lisa Horvath, Tilman Todenhoefer, Arun Azad

Conference Proceedings  |  2018  |  Clinical Research (Excluding Clinical Trials)

Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis-targeting Agents in Metastatic Castration-resistant Prostate Cancer

Sarah Q To, Edmond M Kwan, Heidi C Fettke, Andrew Mant, Maria M Docanto, Luciano Martelotto, Patricia Bukczynska, Nicole Ng, Lisa-Jane K Graham, Phillip Parente, Carmel Pezaro, Kate Mahon, Lisa Horvath, Tilman Todenhoefer, Arun A Azad

Journal article  |  2018  |  European Urology

In 2014, a landmark study was published demonstrating that the expression of androgen receptor splice variant (AR-V) 7 was a negat..

Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial

Jun Guo, Jie Jin, Mototsugu Oya, Hirotsugu Uemura, Shunji Takahashi, Katsunori Tatsugami, Sun Young Rha, Jae-Lyun Lee, Jinsoo Chung, Ho Yeong Lim, Hsi Chin Wu, Yen Hwa Chang, Arun Azad, Ian D Davis, Marlene J Carrasco-Alfonso, Bhupinder Nanua, Jackie Han, Qasim Ahmad, Robert Motzer

Journal article  |  2018  |  Journal of Hematology & Oncology

Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer.

Matti Annala, Gillian Vandekerkhove, Daniel Khalaf, Sinja Taavitsainen, Kevin Beja, Evan W Warner, Katherine Sunderland, Christian Kollmannsberger, Bernhard J Eigl, Daygen Finch, Conrad D Oja, Joanna Vergidis, Muhammad Zulfiqar, Arun A Azad, Matti Nykter, Martin E Gleave, Alexander W Wyatt, Kim N Chi

Journal article  |  2018  |  Cancer Discovery

Primary resistance to androgen receptor (AR)-directed therapies in metastatic castration-resistant prostate cancer (mCRPC) is poor..

Use of Bone-Modifying Agents in Australian Men with Castration-Resistant Prostate Cancer (CRPC)

Angelyn Anton, Phillip Parente, Arun Azad, Andrew Weickhardt, Shirley Wong, Julia Shapiro, Javier Torres, Francis Parnis, Christine Semira, Peter Gibbs, Ben Tran, Carmel Pezaro

Conference Proceedings  |  2018  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Whole blood AR-V7 and AR-V9 mRNA expression and treatment response in metastatic castrate-resistant prostate cancer (mCRPC).

Edmond Michael Kwan, Sarah To, Heidi Fettke, Andrew Michael Mant, Maria Docanto, Luciano Martelotto, Patricia Bukczynska, Nicole Ng, Lisa-Jane Graham, Phillip Parente, Carmel Jo Pezaro, Kate Lynette Mahon, Lisa Horvath, Tilman Todenhofer, Arun Azad

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate

DJ Khalaf, CM Avilés, AA Azad, K Sunderland, T Todenhöfer, BJ Eigl, D Finch, L Le, A Atwell, B Keith, C Kollmannsberger, KN Chi

Journal article  |  2018  |  Canadian Urological Association Journal

Introduction: Recently, a prognostic index including six risk factors (RFs) (unfavourable Eastern Cooperative Oncology Group perfo..

Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre - impact on clinical decision-making and implications for patient inclusion

Kenny Rao, Kiran Manya, Arun Azad, Nathan Lawrentschuk, Damien Bolton, Ian D Davis, Shomik Sengupta

Journal article  |  2014  |  BJU International

Co-targeting Deoxyribonucleic Acide-Dependent Protein Kinase and Poly(Adenosine Diphosphate-Ribose) Polymerase-1 Promotes Accelerated Senescence of Irradiated Cancer Cells

Arun Azad, Patricia Bukczynska, Susan Jackson, Ygal Haput, Carleen Cullinane, Grant A McArthur, Benjamin Solomon

Journal article  |  2014  |  International Journal of Radiation: Oncology - Biology - Physics

USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer

Mun Sem Liew, Arun Azad, Ali Tafreshi, Renu Eapen, Damien Bolton, Ian D Davis, Shomik Sengupta

Journal article  |  2013  |  BJU International

Inhibition of DNA-Dependent Protein Kinase Induces Accelerated Senescence in Irradiated Human Cancer Cells

Arun Azad, Susan Jackson, Carleen Cullinane, Anthony Natoli, Paul M Neilsen, David F Callen, Sauveur-Michel Maira, Wolfgang Hackl, Grant A McArthur, Benjamin Solomon

Journal article  |  2011  |  Molecular Cancer Research

High Impact of F-18-FDG-PET on Management and Prognostic Stratification of Newly Diagnosed Small Cell Lung Cancer

Arun Azad, Fiona Chionh, Andrew M Scott, Szeting T Lee, Sam U Berlangieri, Shane White, Paul L Mitchell

Journal article  |  2010  |  Molecular Imaging and Biology

Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab

Hui K Gan, Arun Azad, Lawrence Cher, Paul LR Mitchell

Journal article  |  2010  |  Neuro-Oncology